Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2000, p. 444-447, Vol. 38, No. 1
PHLS Mycobacterium Reference Unit, Department
of Microbiology, Dulwich Public Health Laboratory, Guy's King's and
St Thomas' Medical School, Dulwich Hospital, London SE22 8QF, United
Kingdom
Received 3 August 1999/Returned for modification 10 September
1999/Accepted 28 October 1999
A blinded comparison of peptide nucleic acid-fluorescence in situ
hybridization (PNA-FISH) with routine identification methods was
performed on 74 consecutively positive mycobacterial liquid cultures.
All Mycobacterium tuberculosis cultures (48 of 48) and 22 of 27 (81.5%) nontuberculous cultures were correctly identified (including one mixed culture). Five isolates yielded no reaction with
either probe and were identified as Mycobacterium xenopi, Mycobacterium fortuitum, or Mycobacterium
flavescens.
Eight million new cases of
tuberculosis (TB) occur annually in the world, producing almost 3 million deaths, and in 1993, the World Health Organization declared TB
to be a global emergency (3). The decline in TB cases in
industrialized countries and parts of the developing world ceased or
reversed in the mid-1980s. Drug resistance has compromised the
successful treatment of TB cases, and multidrug-resistant TB (i.e.,
having resistance to at least isoniazid and rifampin) has caused high
morbidity and mortality, particularly in immunocompromised populations
(2, 9). Outbreaks of both drug-sensitive and drug-resistant
TB, particularly multidrug-resistant TB, have occurred in both
immunocompetent and immunocompromised patients (2, 4, 7,
11). The ability to identify Mycobacterium
tuberculosis complex (MTC) isolates and differentiate them from
nontuberculous mycobacteria (NTM) is therefore of importance for
patient management, hospital control of infection, and public health TB
control services.
Several in-house and commercial systems for the rapid identification of
mycobacterial species isolated from clinical specimens exist, such as
the Accuprobe system (GenProbe, San Diego, Calif.), which includes
tests for the identification of the MTC, Mycobacterium avium
complex, M. avium, Mycobacterium intracellulare,
Mycobacterium kansasii, and Mycobacterium
gordonae. The system is highly specific, but a separate test must
be performed for each species (8). High-performance liquid
chromatography analysis of mycolic acids (6), DNA sequencing
of the 16S rRNA gene (10), and 65-kDa hsp PCR
restriction enzyme assays (12) have been used successfully. Novel commercial systems for the identification of multiple
mycobacterial species have been described, including high-density DNA
probe arrays on a "microchip" system (5, 13). The latter
system has been commercially developed, but the cost of specialized
analytical equipment is high.
In most laboratories, smears of putative mycobacterial cultures are
prepared to confirm the presence of acid-fast bacilli, detect gross
contamination, and, in experienced reference centers, make a tentative
separation of MTC and NTM cultures. Unlike solid cultures, only the
microscopic appearance of mycobacteria is available for liquid
cultures, which is not a reliable distinguishing indicator alone. The
culture would normally be identified with a combination of growth and
microscopic characteristics, biochemical assays, and high-performance
liquid chromatography or DNA hybridization tests (7).
A new commercial culture confirmation system which utilizes the
hydrophobic character of peptide nucleic acid (PNA) probes, enabling
them to penetrate the mycobacterial cell wall and bind with high
specificity to MTC- and NTM-specific rRNA sequences, has been
developed. The system detects binding of PNA oligomers (15 oligonucleotides) to MTC-specific and NTM-specific 23S and 16S rRNA
sequences, respectively, by a fluorescence in situ hybridization (FISH)
system and microscopic techniques familiar to microbiology laboratories
(11a).
The aim of the study was to perform a blinded comparison of the DAKO
MTC culture confirmation system (Glostrup, Denmark) on liquid
mycobacterial cultures from the Organon Teknika MB/BacT 3D
nonradiometric culture system (Cambridge, United Kingdom). We
prospectively compared the performance of the new PNA-FISH system with
conventional methodology used at the United Kingdom Public Health
Laboratory Service Mycobacterium Reference Unit. We believe that this
is the first study to demonstrate the use of a commercial PNA-FISH
system for mycobacterial identification with liquid cultures.
Sequential positive liquid mycobacterial cultures from the continuously
monitored and automated Organon Teknika MB/BacT 3D system were used in
a prospective blinded analysis. The medium is based on Middlebrook 7H9
broth. Cultures were analyzed by the PNA-FISH assay and then were
analyzed conventionally by macroscopic appearance after subculture,
microscopic appearance of Ziehl-Neelsen-stained smears, and growth and
biochemical characteristics. Identity was confirmed with DNA
hybridization systems (Accuprobe; GenProbe) and thin-layer
chromatography or PCR-restriction enzyme analysis (1, 8,
12). Drug susceptibility testing was performed by the resistance
ratio method on solid Lowenstein-Jensen medium as previously described
(1).
The methodology used was as described in the documentation supplied by
the manufacturer, DAKO A/S, with modifications. Approximately 1 ml of
acid-fast bacillus-positive liquid culture was transferred from the
MB/BacT culture vial into a clean screw-top Microfuge tube and
centrifuged at 13,000 × g for 5 min (model no. 5417C; Eppendorf, Hamburg, Germany). The supernatant was carefully removed, 100 to 200 µl of phosphate-buffered saline was added to each tube, depending on the size of deposit visible, and the contents were mixed.
From this, 25 µl was added to each of two wells on the supplied
two-well slide. The slide was allowed to air dry (approximately 30 min)
before fixing the smears by passing the slide through a Bunsen burner
flame three or four times and then immersing it in 80% (vol/vol)
ethanol for 15 min. The slide was then air dried for a further 10 min.
One drop of the fluoroscein isothiocyanate (FITC)-labelled MTC PNA
conjugate was added to one well, and one drop of FITC-labelled NTM PNA
conjugate was added to the other well. A coverslip (22 by 22 by 0.15 mm) was added to each well, and the slide was incubated in a humidity
chamber for 90 min at 55°C. The wash solution was prepared and
preheated to 55°C. The coverslips were removed, and the slides were
immersed in wash solution for 30 min at 55°C. They were then dipped
in distilled water for 30 s and air dried for 10 min. One drop of
mounting fluid was added to each well, and the wells were covered with a double coverslip (24 by 60 by 0.15 mm) and incubated in a humidity chamber for 30 min at 55°C. The smears were examined with a
fluorescent microscope equipped with a FITC-Texas Red dual-band filter
set and a 100× oil objective (Hund) (5 min per slide) (total
magnification, ×1,000). Mycobacteria were detected on the basis of
green fluorescence against a red-brown background and characteristic
morphology. MTC appears as a 1- to 3-µm slender, rod-shaped bacillus
which may show cording. NTM species vary in morphology. The intensity of fluorescence may vary, depending on growth medium and species.
The results are given in Table
1. A total of 74 cultures
were prospectively analyzed by the usual reference laboratory
procedures; 47 cultures were shown to be MTB alone, one was a mixture
of MTC and NTM, and 26 were NTM alone. The mean time taken to culture M. tuberculosis from all specimens and from sputum isolates
was 17.6 days (range, 6 to 45 days) and 15.2 days (range, 6 to 38 days), respectively. Nontuberculous isolates were cultured for a mean
of 16 days (range, 5 to 30 days). The PNA-FISH system correctly identified all MTB cultures (48 of 48), and 22 of 27 (81.5%) NTM cultures were correctly identified as NTM. Two M. tuberculosis strains which subsequently showed isoniazid
resistance were also correctly identified by the PNA system, which is
of importance since resistance is associated with changes in mycolic
acid synthesis and bacterial surface properties. The five NTM cultures
which gave no reaction with either of the two probes were identified as
Mycobacterium xenopi, Mycobacterium fortuitum
(2), and Mycobacterium flavescens. Overall, no
result was obtained in 5 of 74 (6.8%) total cultures flagged positive
for mycobacteria.
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Differentiation of Mycobacterium
tuberculosis Complex and Nontuberculous Mycobacterial Liquid
Cultures by Using Peptide Nucleic Acid-Fluorescence In Situ
Hybridization Probes
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
TABLE 1.
Prospective consecutive samples analyzed by PNA-FISH and
conventional methodology
In general, the new culture confirmation system performed well, identifying all M. tuberculosis cultures analyzed. A weak signal was seen in 7 of the 48 MTC-containing cultures (14.6%), although in half the cultures, few mycobacteria were seen by direct microscopy with Ziehl-Neesen staining. Five NTM cultures were not identified by PNA-FISH. Earlier data obtained with pure cultures had suggested that the NTM probe was not complementary to rRNA from Mycobacterium marinum, M. xenopi, M. flavescens, and M. fortuitum, so these species would not be recognized by the assay (11a). The NTM probe is complementary (and so cross-reacts) to rRNA from species of Actinomyces and Rickettsia (11a). Neither probe cross-reacts with rRNA from Corynebacterium or Neisseria species or from Haemophilus influenzae, Klebsiella pneumoniae, Pseudomonas aeruginosa, Propionibacterium acnes, Streptococcus pneumoniae, Staphylococcus aureus, Moraxella catarrhalis, Escherichia coli, and Nocardia asteroides (11a).
The new system is principally targeted at the niche occupied by the Accuprobe system, which is able to identify cultures of the MTC, the M. avium-M. intracellulare complex, M. avium, M. kansasii, and M. gordonae. Neither the new assay nor the Accuprobe system is able to differentiate between members of the MTC or identify all NTM isolates. The fluorescent assay is able to identify a broader range of NTM species than the Accuprobe but cannot distinguish between species. It does permit direct visualization of mycobacteria which, in the hands of experienced reference staff, can support the provisional identification of MTC by macroscopic and microscopic appearances even when low fluorescence due to a small organism load is a problem. Routine clinical laboratories examining few mycobacterial cultures may have difficulty with tests yielding low fluorescence, which was a problem with some cultures, particularly NTM. The test, however, does allow for a second opinion in tests exhibiting borderline results, in that the slides can be reviewed. The identification of mixed mycobacterial cultures is also possible, as occurred in this study. It is less likely that smaller clinical laboratories seeing few mycobacterial cultures would be as successful, as low fluorescence was the most consistent problem with the FISH, particularly when examining NTM. The systems use comparable levels of general laboratory equipment; a luminometer is required for the Accuprobe system, and an appropriately modified FITC-Texas Red filter set needs to be fitted to the microscope to obtain reproducible results with the FISH assay. These additional costs would probably prohibit small laboratories and those in the developing parts of the world from utilizing the FISH assay. The overall times needed to perform the assays are comparable.
In conclusion, the new FISH assay offers a useful alternative to current methods for identifying MTC cultures in reference laboratories.
| |
ACKNOWLEDGMENTS |
|---|
DAKO TB Probe Culture Confirmation Kits were supplied by DAKO A/S. We acknowledge the kind support and helpful discussions of Henrik Stender and Ole Rasmussen.
The study was funded by DAKO A/S and the UK Public Health Laboratory Service.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: PHLS Mycobacterium Reference Unit, Department of Microbiology, Dulwich Public Health Laboratory, Guy's King's and St. Thomas' Medical School, Dulwich Hospital, East Dulwich Grove, London SE22 8QF, United Kingdom. Phone: 181 693 1312. Fax: 171 346 6477. E-mail: francis.drobniewski{at}kcl.ac.uk.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Collins, C. H., J. M. Grange, and M. D. Yates. 1997. Tuberculosis bacteriology, organisation and practice, 2nd ed. Butterworth-Heineman, Oxford, United Kingdom. |
| 2. | Drobniewski, F. A. 1997. Is death inevitable with multi-resistant TB plus HIV infection? Lancet 349:71-72[CrossRef][Medline]. |
| 3. | Drobniewski, F. A., A. Pablos-Mendes, and M. R. Raviglione. 1997. Epidemiology of tuberculosis in the world. Semin. Respir. Crit. Care Med. 18:419-429. |
| 4. | Fischl, M. A., R. B. Uttamchandani, G. L. Daikos, R. Poblete, J. Moreno, R. Reyes, A. M. Boota, L. M. Thompson, T. J. Cleary, and S. Lai. 1992. An outbreak of TB caused by multi-drug resistant tubercle bacilli among patients with HIV infection. Ann. Intern. Med. 117:177-183. |
| 5. |
Gingeras, T. R.,
G. Ghandour,
E. Wang,
A. Berno,
P. M. Small,
F. Drobniewski,
D. Alland,
E. Desmond,
M. Holodniy, and J. Drenkow.
1998.
Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays.
Genome Res.
8:435-448 |
| 6. |
Glickman, S. E.,
J. O. Kilburn,
W. R. Butler, and L. S. Ramos.
1994.
Rapid identification of mycolic acid patterns of mycobacteria by high-performance liquid chromatography using pattern recognition software and a Mycobacterium library.
J. Clin. Microbiol.
32:740-745 |
| 7. |
Goble, M.,
M. D. Iseman,
L. A. Madsen,
D. Waite,
L. Ackerson, and C. R. Horsburgh.
1993.
Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
N. Engl. J. Med.
328:527-532 |
| 8. | Heifets, L. B., and R. B. Good. 1994. Current laboratory methods for the diagnosis of tuberculosis, p. 85-110. In B. R. Bloom (ed.), Tuberculosis protection, pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C. |
| 9. |
Iseman, M. D.
1993.
Treatment of multidrug-resistant tuberculosis.
N. Engl. J. Med.
329:784-791 |
| 10. | Kirschner, P., and E. C. Böttger. 1998. Species identification of mycobacteria using rDNA sequencing, p. 349-361. In T. Parish, and N. G. Stoker (ed.), Mycobacteria protocols. Humana Press, Totowa, N.J. |
| 11. |
Small, P. M.,
R. W. Shafer,
P. C. Hopewell,
S. P. Singh,
M. J. Murphy,
E. Desmond,
M. F. Sierra, and G. K. Schoolnik.
1993.
Exogenous reinfection with multi-drug resistant Mycobacterium tuberculosis in patients with advanced HIV infection.
N. Engl. J. Med.
328:1137-1144 |
| 11a. |
Stender, H.,
K. Lund,
K. H. Petersen,
O. F. Rasmussen,
P. Hongmanee,
H. Miörner, and S. E. Godtfredsen.
1999.
Fluorescence in situ hybridization assay, using peptide nucleic acid probes for differentiation between tuberculous and nontuberculous mycobacterium species in smears of mycobacterium cultures.
J. Clin. Microbiol.
37:2760-2765 |
| 12. |
Telenti, A.,
F. Marchesi,
M. Balz,
F. Bally,
E. C. Böttger, and T. Bodmer.
1993.
Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.
J. Clin. Microbiol.
31:175-178 |
| 13. |
Troesch, A.,
C. Nguyen,
C. G. Miyada,
S. Desvarenne,
T. R. Gingeras,
P. M. Kaplan,
P. Cros, and C. Mabilat.
1999.
Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays.
J. Clin. Microbiol.
37:49-55 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|